TWD 16.4
(1.55%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 368.33 Million TWD | 11.41% |
2022 | 330.6 Million TWD | 90.17% |
2021 | 173.84 Million TWD | -29.78% |
2020 | 247.55 Million TWD | 11.18% |
2019 | 222.66 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 479.35 Million TWD | 0.0% |
2024 Q1 | 479.35 Million TWD | 30.14% |
2023 FY | 368.33 Million TWD | 11.41% |
2023 Q3 | 368.33 Million TWD | 36.11% |
2023 Q2 | 270.6 Million TWD | 0.0% |
2023 Q4 | 368.33 Million TWD | 0.0% |
2023 Q1 | 270.6 Million TWD | -18.15% |
2022 Q3 | 330.6 Million TWD | 0.0% |
2022 Q4 | 330.6 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 36.874% |
Level Biotechnology Inc. | 273.2 Million TWD | -34.821% |
Sagittarius Life Science Corp | 137.82 Million TWD | -167.247% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | -86.524% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 72.261% |
GlycoNex Incorporation | 276.39 Million TWD | -33.261% |
VBI | 21.25 Million TWD | -1633.241% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | -17.413% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 28.431% |
Visgeneer Inc. | 185.6 Million TWD | -98.449% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 72.164% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 49.749% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -207.301% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 83.601% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -5465.594% |
Enimmune corporation | 173.46 Million TWD | -112.34% |
TaiRx, Inc. | 60.62 Million TWD | -507.556% |
CHO Pharma, Inc. | 110.83 Million TWD | -232.333% |
EirGenix Inc. | 1.14 Billion TWD | 67.834% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -228.923% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 28.122% |
Lin BioScience, Inc. | 167.73 Million TWD | -119.598% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -293.037% |
Feng Chi Biotech Corp. | 63.03 Million TWD | -484.337% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | -195.305% |
Lukas Biomedical Inc. | 161.05 Million TWD | -128.693% |
RBC Bioscience Corporation | 513.08 Million TWD | 28.212% |
BiOptic Inc. | 170.56 Million TWD | -115.95% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -773.692% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -1483.879% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -1273.703% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 62.208% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -5166.385% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -1635.282% |
Neith Corporation | 17.43 Million TWD | -2012.838% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -4520.309% |
NaviFUS Corp. | 53.4 Million TWD | -589.746% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 23.501% |
Sinew Pharma Inc. | 39.71 Million TWD | -827.459% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -534.627% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | -1.058% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -61.766% |
AP Biosciences Inc | 106.65 Million TWD | -245.364% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 89.566% |
3D Global Biotech Inc. | 30.68 Million TWD | -1100.518% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | -87.934% |
Intech Biopharm Corporation | 1.54 Billion TWD | 76.132% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 57.489% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -3870.796% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -559.938% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -58.11% |
TCI GENE Inc. | 155.54 Million TWD | -136.796% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -1343.982% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -697.685% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | -12.135% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -467.65% |
PharmaEngine, Inc. | 91 Million TWD | -304.733% |
Savior Lifetec Corporation | 457.95 Million TWD | 19.571% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -232.009% |
OBI Pharma, Inc. | 650.44 Million TWD | 43.373% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 5.752% |
Acepodia, Inc. | 384.47 Million TWD | 4.198% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -330.53% |